Study identifies a common hidden genetic cause of neurodevelopmental disorder in children

By Vijay Kumar MalesuReviewed by Susha Cheriyedath, M.Sc.Apr 2 2026

A major genetic study has uncovered a surprisingly common recessive cause of neurodevelopmental disorder, revealing how hidden changes in a small RNA gene can disrupt brain development and open new paths for diagnosis and family counseling.

Study: Biallelic variants in RNU2-2 cause the most prevalent known recessive neurodevelopmental disorder. Image Credit: Lightspring / Shutterstock

In a recent study published in Nature Genetics, a group of researchers identified and characterized recessive neurodevelopmental disorders caused by biallelic variants in the RNU2-2 gene and investigated their clinical and molecular features.

Background

Neurodevelopmental disorders affect millions of children worldwide, often leading to lifelong cognitive, behavioral, and physical challenges. While many cases remain genetically unexplained, advances in sequencing have revealed that even small non-coding ribonucleic acids (RNAs), such as small nuclear RNA (snRNA), play critical roles in brain development.

RNA splicing requires the assistance of non-coding RNAs; therefore, they are critically important to RNA's overall function. The possibility that alterations in the splicing process could play a role in disease development has not been extensively studied.

It is essential to identify how changes in non-coding RNA genes can affect neurological disorders to provide clinicians with diagnostic tools and guide future therapeutic development. There is a significant knowledge gap regarding the genetic basis of disease, and further research is needed to fill it.

About the study

The researchers conducted a large-scale genetic association study using data from the 100,000 Genomes Project (100KGP), the Genomic Medicine Service (GMS), and the National Genomic Research Library (NGRL).

The analysis included 14,805 individuals with neurodevelopmental disorders and 52,861 controls without such conditions. A statistical method, Bayesian evaluation of variant involvement in Mendelian disease (BeviMed), was applied to identify rare variants associated with disease.

Researchers analyzed RNU2-2 gene variants using dominant and recessive models. Read-backed phasing techniques were used to determine whether variants occurred on the same chromosome (cis) or on different chromosomes (trans), enabling identification of biallelic cases. Variants were classified according to their likelihood of causing disease.

Independent datasets of the Undiagnosed Diseases Network (UDN), the Undiagnosed Patients Program (UPP), and Erasmus Medical Center (Erasmus MC) participants were also analyzed to confirm results. Clinical phenotypes were evaluated according to Human Phenotype Ontology (HPO) terms. Moreover, whole-blood RNA sequencing (RNA-seq) data from selected participants were analyzed to determine gene expression levels and to investigate molecular mechanisms underlying the disorder.

Study results

The study identified strong statistical evidence for a link between biallelic variants in the RNU2-2 gene and a recessive neurodevelopmental disorder. A high log Bayes factor of 18.2 supported the recessive inheritance model, indicating a robust association. Researchers identified 18 high-confidence probands (tier 1), with 5 additional affected siblings, and 13 lower-confidence candidate probands (tier 2).

Clinical exams showed a shared core pattern of symptoms rather than a completely uniform presentation, as the majority of affected individuals had intellectual disability, global developmental delay, and seizures. Seizure disorders were present in over 90% of tier 1 cases in the 100KGP cohort; developmental delay and related neurological features were also common across affected individuals. Additional diagnostic findings include electroencephalographic abnormalities, motor impairments, and skeletal abnormalities, including microcephaly.

Replication across independent cohorts further confirmed the findings. Nine additional cases from international datasets exhibited similar genetic and clinical profiles, reinforcing the reliability of the association. It was also observed that individuals carrying only one variant did not show any reported neurodevelopmental disorder-related symptoms, which supports the disease being recessive.

At the molecular level, RNA sequencing revealed a dramatic reduction of over 90% in the expression of mutated RNU2-2 alleles in affected individuals. However, carriers showed partial compensation through increased expression of the normal allele. This suggests that the disease arises from a loss-of-function mechanism rather than a toxic gain-of-function.

Structural modeling predicted that the pathogenic variants compromise critical stem-loop structures of the U2-2 snRNA, implicating an essential role for this sequence in spliceosome function. These disruptions are predicted to impair aspects of RNA splicing, an essential process necessary for correct gene expression. Nonetheless, splicing defects were not consistently detected and may have been missed due to tissue specificity or the limited number of available samples.

This disorder is likely one of the most prevalent identified recessive neurodevelopmental disorders currently diagnosable by sequencing, accounting for approximately 10% of all families with a recessive neurodevelopmental disorder that can presently be diagnosed by sequencing, and is roughly 60% as common as the dominant RNU4-2-related ReNU syndrome. Furthermore, it has been shown to be prevalent in both consanguineous and non-consanguineous populations, thereby suggesting that it may be an important and underrecognized cause of disease across populations.

Conclusions

Biallelic mutations in the RNU2-2 gene represent a significant and previously underestimated cause of recessive neurodevelopmental disorders. This finding emphasizes that non-coding RNA plays a vital role in human disease and that disruption of RNA splicing machinery can cause significant neurological impairment.

Identifying a relatively common genotypically diagnosable condition has important implications for the clinical setting, including genetic counseling, early diagnosis, and potentially preconception or prenatal genetic counseling in affected families.